David Steel, MD, MBBS, FRCOphth
Show Description +
Dr. Steel discusses the value of using anti-VEGF therapy to manage diabetic vitreous haemorrhage in select patients, and how it can help address hemorrhage post-PPV for PDR.
Posted: 10/01/2024
David Steel, MD, MBBS, FRCOphth
Dr. Steel discusses the value of using anti-VEGF therapy to manage diabetic vitreous haemorrhage in select patients, and how it can help address hemorrhage post-PPV for PDR.
Posted: 10/01/2024
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of EURETINA: 2024.
Please log in to leave a comment.